The Role of Serial NT-ProBNP Level in Prognosis and Follow-Up Treatment of Acute Heart Failure after Coronary Artery Bypass Graft Surgery
DOI:
https://doi.org/10.3889/oamjms.2019.872Keywords:
N-terminal pro-B-type natriuretic peptide (NT-proBNP), serial measurements, acute heart failure (AHF), coronary artery bypass graft surgery (CABG), prognosis, follow-up treatmentAbstract
BACKGROUND: After coronary artery bypass graft (CABG) surgery, heart failure is still major problem. The valuable marker for it is needed.
AIM: Evaluating the role of serial NT-proBNP level in prognosis and follow-up treatment of acute heart failure after CABG surgery.
METHODS: The prospective, analytic study evaluated 107 patients undergoing CABG surgery at Ho Chi Minh Heart Institute from October 2012 to June 2014. Collecting data was done at pre- and post-operative days with measuring NT-proBNP levels on the day before operation, 2 hours after surgery, every next 24 h until the 5th day, and in case of acute heart failure occurred after surgery.
RESULTS: On the first postoperative day (POD1), the NT-proBNP level demonstrated significant value for AHF with the cut-off point = 817.8 pg/mL and AUC = 0.806. On the second and third postoperative day, the AUC value of NT- was 0.753 and 0.751. It was statistically significant in acute heart failure group almost at POD 1 and POD 2 when analyzed by the doses of dobutamine, noradrenaline, and adrenaline (both low doses and normal doses).
CONCLUSION: Serial measurement of NT-proBNP level provides useful prognostic and follow-up treatment information in acute heart failure after CABG surgery.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
O'Connor GT, et al. Results of a regional study of modes of death associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg. 1998; 66(4):1323-8.
Roques F, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg. 1999; 15(6):816-22; discussion 822-3. https://doi.org/10.1016/S1010-7940(99)00106-2
Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation. 1989; 79(6 Pt 2):I3-12.
Wynne-Jones K, et al. Limitations of the Parsonnet score for measuring risk stratified mortality in the north west of England. The North West Regional Cardiac Surgery Audit Steering Group. Heart. 2000; 84(1):71-8. https://doi.org/10.1136/heart.84.1.71 PMid:10862595 PMCid:PMC1729412
Bhatti F, et al. The logistic EuroSCORE in cardiac surgery: how well does it predict operative risk? Heart. 2006; 92(12):1817-20. https://doi.org/10.1136/hrt.2005.083204 PMid:16547206 PMCid:PMC1861312
Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006; 92(6):843-849. https://doi.org/10.1136/hrt.2005.071233 PMid:16698841 PMCid:PMC1860679
Cuthbertson BH, et al. N-terminal pro-B-type natriuretic peptide levels and early outcome after cardiac surgery: a prospective cohort study. Br J Anaesth. 2009; 103(5):647-53. https://doi.org/10.1093/bja/aep234 PMid:19713279
Cuthbertson BH, et al. N-terminal pro-B-type natriuretic peptide concentrations and long-term outcome after cardiac surgery: a prospective cohort study. Br J Anaesth. 2013; 110(2):214-21. https://doi.org/10.1093/bja/aes379 PMid:23183321
McKelvie RS, et al. The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Canadian Journal of Cardiology. 2013; 29(2):168-181. https://doi.org/10.1016/j.cjca.2012.10.007 PMid:23201056
Members ATF, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European journal of heart failure. 2012; 14(8):803-869.
Holm J, et al. Preoperative NT-proBNP independently predicts outcome in patients with acute coronary syndrome undergoing CABG. Scand Cardiovasc J Suppl. 2013; 47(1):28-35. https://doi.org/10.3109/14017431.2012.731518 PMid:22989031
Holm J, et al. EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery bypass graft surgery. Br J Anaesth. 2014; 113(1):75-82. https://doi.org/10.1093/bja/aeu088 PMid:24727704
Polineni S, et al. Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery. J Am Heart Assoc. 2018; 7(14). https://doi.org/10.1161/JAHA.117.008371 PMid:29982227 PMCid:PMC6064859
Newton PJ, Betihavas V, Macdonald P. The role of b-type natriuretic peptide in heart failure management. Aust Crit Care. 2009; 22(3):117-23. https://doi.org/10.1016/j.aucc.2009.06.001 PMid:19589695
Bhardwaj A, Januzzi Jr. JL. Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm. Crit Pathw Cardiol. 2009; 8(4):146-50. https://doi.org/10.1097/HPC.0b013e3181c4a0c6 PMid:19952548
Di Angelantonio E, et al. B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation. 2009; 120(22):2177-87. https://doi.org/10.1161/CIRCULATIONAHA.109.884866 PMid:19917883
Bettencourt P, et al. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation. 2004; 110(15):2168-74. https://doi.org/10.1161/01.CIR.0000144310.04433.BE PMid:15451800
Franke J, et al. Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy? Clin Res Cardiol. 2011; 100(12):1059-67. https://doi.org/10.1007/s00392-011-0340-1 PMid:21779816
Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem. 2004; 50(1):33-50. https://doi.org/10.1373/clinchem.2003.024760 PMid:14633912
Nashef SA, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012; 41(4):734-44; discussion 744-5.
Eliasdottir SB, et al. Brain natriuretic peptide is a good predictor for outcome in cardiac surgery. Acta Anaesthesiol Scand. 2008; 52(2):182-7. https://doi.org/10.1111/j.1399-6576.2007.01451.x PMid:17949462
Jaberg L, et al. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes undergoing left main percutaneous coronary intervention. Circ J. 2011; 75(11):2648-53. https://doi.org/10.1253/circj.CJ-11-0095 PMid:21891968
Jiang H, et al. NT-proBNP and postoperative heart failure in surgery for aortic stenosis. Open Heart. 2019; 6(1):e001063. https://doi.org/10.1136/openhrt-2019-001063 PMid:31218010 PMCid:PMC6546186
Hinderliter AL, et al. Independent prognostic value of echocardiography and N-terminal pro-B-type natriuretic peptide in patients with heart failure. Am Heart J. 2008; 156(6):1191-5. https://doi.org/10.1016/j.ahj.2008.07.022 PMid:19033018 PMCid:PMC3665504
Jiang H, et al. Impact of underlying heart disease per se on the utility of preoperative NT-proBNP in adult cardiac surgery. PloS one. 2018; 13(2):e0192503. https://doi.org/10.1371/journal.pone.0192503 PMid:29420603 PMCid:PMC5805306
McCullough PA, et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. American Journal of Kidney Diseases. 2003; 41(3):571-579. https://doi.org/10.1053/ajkd.2003.50118 PMid:12612980
Chenevier-Gobeaux C, et al. Influence of renal function on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients admitted for dyspnoea in the Emergency Department: comparison with brain natriuretic peptide (BNP). Clin Chim Acta. 2005; 361(1-2):167-75. https://doi.org/10.1016/j.cccn.2005.05.021 PMid:15993397
Balion C, et al. Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure. Evid Rep Technol Assess (Full Rep). 2006; 142:1-147.
Fellahi JL, et al. Does preoperative B-type natriuretic peptide better predict adverse outcome and prolonged length of stay than the standard European System for Cardiac Operative Risk Evaluation after cardiac surgery? J Cardiothorac Vasc Anesth. 2011; 25(2):256-62. https://doi.org/10.1053/j.jvca.2010.05.009 PMid:20674395
Pedrazzini GB, et al. Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis. Am J Cardiol. 2008; 102(6):749-54. https://doi.org/10.1016/j.amjcard.2008.04.055 PMid:18774001
De Maria R, et al. Predictive value of EuroSCORE on long term outcome in cardiac surgery patients: a single institution study. Heart. 2005; 91(6):779-784. https://doi.org/10.1136/hrt.2004.037135 PMid:15894777 PMCid:PMC1768917
Luers C, et al. Serial NT-proBNP measurements for risk stratification of patients with decompensated heart failure. Herz. 2010; 35(7):488-95. https://doi.org/10.1007/s00059-010-3377-4 PMid:20927502
Sargento L, et al. Serial measurements of the Nt-ProBNP during the dry state in patients with systolic heart failure are predictors of the long-term prognosis. Biomarkers. 2014; 19(4):302-13. https://doi.org/10.3109/1354750X.2014.910549 PMid:24735006
Januzzi JL, Troughton R. Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management. Circulation. 2013; 127(4):500-7; discussion 508. https://doi.org/10.1161/CIRCULATIONAHA.112.120485 PMid:23357662
Bayes-Genis A, et al. Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure. Int J Cardiol. 2007; 120(3):338-43. https://doi.org/10.1016/j.ijcard.2006.10.009 PMid:17174423
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Bui Duc Thanh, Nguyen Hong Son, Dinh Cong Pho, Dinh Toi Chu, Nguyen Duy Bac, Vu Thi Nga, Quan Anh Dung, Do Duc Anh, Do Dieu Linh, Hoang Thi Bich Viet, Bui Dang The Anh, Ha The Tan, Pham Ngoc Hung (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)
